Skip to
  1. Homepage
  2. Research and trials
  3. Research projects
Search by disease/gene

Search by disease/gene

*
(*) mandatory field


 

Other search option(s)

22 matching term(s)

Partnership : Academics = Academics, Industrials = Industrials, Financial investitors = Financial investitors

    • FINLAND
    • Finland
    • HELSINKI
    • AcademicsFinancial investitors
    • Inherited chorioretinal dystrophies of Finnish children with visual impairment born from 1990 through 2010 (LANVET2 Study)
    • Finnish Federation of the Visually Impaired
    • More details
    • FRANCE
    • ALSACE
    • STRASBOURG
    • Retinis Pigmentosa: validation of the molecular diagnostic using next generation sequencing
    • CHU de Strasbourg - Hôpital Civil
    • Laboratoire de diagnostic génétique
    • More details
    • FRANCE
    • ILE-DE-FRANCE
    • PARIS
    • Epidemiological study in hereditary dystrophies of retina
    • Institut de la Vision
    • Recherche Clinique
    • More details
    • FRANCE
    • LANGUEDOC-ROUSSILLON
    • MONTPELLIER
    • Gene therapy of retinal dystrophy on human models: differentiation of patients iPS cells to retinal cells
    • CHRU de Montpellier - Hôpital Saint-Eloi
    • Equipe Génétique et thérapie des cécités rétiniennes et du nerf optique
    • More details
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies: modifying factors and functional assessment of gene variants (subproject 4)
    • Universitätsklinikum Tübingen
    • Molekulargenetisches Labor
    • More details
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • Phenotype-genotype correlation in hereditary degeneration of the retina and the optic nerve (extended function analysis and differentiation, neuro-ophthalmology, mouse models)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • More details
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From Patients Towards Therapies to each project: Translation of novel diagnostics procedures and evaluation of experimental therapies in hereditary retinal disorders (subproject 2)
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • More details
    • GERMANY
    • Baden-Württemberg
    • TÜBINGEN
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies : validation and application of retina-derived neuroprotective factors to the dystrophic retina (subproject 5 )
    • Universitätsklinikum Tübingen
    • Forschungsinstitut für Augenheilkunde
    • More details
    • GERMANY
    • Bayern
    • ALZENAU
    • HOPE2: Hereditary Retinal Disorders - From patients towards therapies : development of suitable CellBead® systems for preclinical studies and human use including testing of existing CellBeads® for human use in animal studies (subproject 6)
    • Cellmed AG
    • More details
    • GERMANY
    • Bayern
    • REGENSBURG
    • HOPE2: Hereditary Retinal Disorders - From Patients Towards Therapies: Integrated diagnostics in hereditary retinal disorders (subproject 3)
    • Universitätsklinikum Regensburg
    • Zentrum und Institut für Humangenetik Regensburg
    • More details
    • GERMANY
    • Hessen
    • GIEßEN
    • Genotype phenotype correlation of hereditary eye diseases
    • Augenklinik des UKGM am Standort Gießen
    • Klinik und Poliklinik für Augenheilkunde
    • More details
    • GERMANY
    • Hessen
    • GIEßEN
    • Diagnosis and therapy of hereditary retinal diseases
    • Augenklinik des UKGM am Standort Gießen
    • Klinik und Poliklinik für Augenheilkunde
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • BONN
    • Two photon excited fluorescence imaging using a femtosecond Ti:sapphire
    • Universitäts-Augenklinik Bonn
    • Experimental Ophthalmology
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • SIEGBURG
    • Genotype-phenotype correlations and long-term evaluation in inherited retinal dystrophies and optic neuropathies
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • SIEGBURG
    • Optical coherence tomography (OCT), fundus autofluorescence (FAF) and near-infrared autofluorescence (NIA) imaging for early detection and differentiation of retinal dystrophies
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • More details
    • GERMANY
    • Nordrhein-Westfalen
    • SIEGBURG
    • Web-based interactive information for patients with inherited retinal and visual pathway disorders
    • Augenzentrum Siegburg
    • AugenZentrum Siegburg Professor Dr. med. Ulrich Kellner
    • More details
    • ITALY
    • CAMPANIA
    • NAPOLI
    • MicroRNA-Regulated Gene Networks in the Retina
    • TIGEM - Telethon Institute of Genetics and Medicine
    • Laboratorio di Ricerca
    • More details
    • SPAIN
    • Cataluña
    • BARCELONA
    • Design of a genetic diagnostic chip for retinal dystrophies
    • Universitat de Barcelona. Facultat de Biologia
    • Departamento de Genética
    • More details
    • SPAIN
    • Madrid
    • MADRID
    • Study of autosomal recessive retinal dystrophies and others: a) Clinical and molecular characterization by new methodological approaches; b) Identification of new candidate regions
    • Fundación Jiménez Díaz
    • Servicio de Genética Médica
    • More details
    • SWITZERLAND
    • Suisse Alémanique
    • SCHLIEREN
    • The genetic and molecular basis of retinal dystrophies
    • Universität Zürich
    • Institüt für Medizinische Molekulargenetik
    • More details
    • UNITED KINGDOM
    • Cambridgeshire
    • CAMBRIDGE
    • NIHR BioResource - Rare Disease: SPEED - Specialist Pathology: Evaluating Exomes in Diagnostics
    • Wellcome Trust/MRC Building
    • Cambridge Institute for Medical Research
    • More details
    • UNITED KINGDOM
    • West Midlands
    • BIRMINGHAM
    • NIPSIGEN - Clinical translation of non-invasive prenatal diagnosis (NIPD) for single gene disorders (Health Innovation Challenge Fund)
    • Birmingham Women's NHS Foundation Trust
    • Regional Genetics Unit
    • More details